Albireo Pharma, Inc. (ALBO) financial statements (2022 and earlier)

Company profile

Business Address 10 POST OFFICE SQUARE
BOSTON, MA 02109
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
9/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments248,107251,272131,843163,88553,23129,93128,684
Cash and cash equivalents248,107251,272131,843163,88553,23129,93128,684
Receivables3,272  2,915726370 
Inventory, net of allowances, customer advances and progress billings194      
Inventory194      
Prepaid expense5,261      
Other current assets12,096      
Other undisclosed current assets 10,5939,9568501,054560151
Total current assets:268,930261,865141,799167,65055,01130,86128,835
Noncurrent Assets
Property, plant and equipment66847859718717821 
Intangible assets, net (including goodwill)17,26017,26017,26017,26017,26018,26034
Goodwill17,26017,26017,26017,26017,26018,110 
Intangible assets, net (excluding goodwill)     15034
Other noncurrent assets15,1936,0045,413369775518 
Total noncurrent assets:33,12123,74223,27017,81618,21318,79934
TOTAL ASSETS:302,051285,607165,069185,46673,22449,66028,869
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities42,46724,33418,27112,5177,4558,520696
Accounts payable6,5165,2834,7854,3521,350972150
Accrued liabilities35,95119,05113,4868,1656,1057,548192
Employee-related liabilities      354
Debt     3,075 
Derivative instruments and hedges, liabilities     844 
Restructuring reserve      1,313
Other liabilities2,880948653308474207 
Other undisclosed current liabilities     6262
Total current liabilities:45,34725,28218,92412,8257,92912,7082,071
Noncurrent Liabilities
Long-term debt and lease obligation20,82213,1844,186    
Long-term debt, excluding current maturities10,0049,621     
Operating lease, liability10,8183,5634,186
Liabilities, other than long-term debt, including:10,9603,5794,2703542 358
Other liabilities10,9603,5794,270 42 358
Other undisclosed liabilities, other than long-term debt   35   
Other undisclosed noncurrent liabilities49,31462,33144,52849,969  1
Total noncurrent liabilities:81,09679,09452,98450,00442 359
Total liabilities:126,443104,37671,90862,8297,97112,7082,430
Stockholders' equity
Stockholders' equity attributable to parent175,608181,23193,161122,63765,25336,95226,439
Common stock193191127120896321
Treasury stock, value(230)      
Additional paid in capital475,390456,472245,769214,694114,52261,338288,469
Accumulated other comprehensive income (loss)1,105(8,612)6,4524,2931,0011,496 
Accumulated deficit(300,850)(266,820)(159,187)(96,470)(50,359)(25,945)(262,051)
Total stockholders' equity:175,608181,23193,161122,63765,25336,95226,439
TOTAL LIABILITIES AND EQUITY:302,051285,607165,069185,46673,22449,66028,869

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
9/30/2016
Revenues40,5798,3089,63612,740111,364 
Revenue, net111,364 
Cost of revenue(1,356)      
Gross profit:39,2238,3089,63612,740111,364 
Operating expenses(162,708)(104,579)(70,748)(50,630)(24,578)(23,658)(13,971)
Operating loss:(123,485)(96,271)(61,112)(37,890)(24,577)(12,294)(13,971)
Nonoperating income (expense)(10,423)14,5733,691(3,363)335(2,675) 
Foreign currency transaction gain (loss), before tax(10,423)14,573(4,006)(4,631)   
Loss from continuing operations before equity method investments, income taxes:(133,908)(81,698)(57,421)(41,253)(24,242)(14,969)(13,971)
Other undisclosed income (loss) from continuing operations before income taxes99,878(25,935)(5,296)(4,838)40(1,319)268
Loss from continuing operations before income taxes:(34,030)(107,633)(62,717)(46,091)(24,202)(16,288)(13,703)
Income tax expense   (20)(212)(62)(52)
Net loss available to common stockholders, diluted:(34,030)(107,633)(62,717)(46,111)(24,414)(16,350)(13,755)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
9/30/2016
Net loss:(34,030)(107,633)(62,717)(46,111)(24,414)(16,350)(13,755)
Other comprehensive income (loss)9,717(15,064)2,1593,292(495)692 
Comprehensive loss, net of tax, attributable to parent:(24,313)(122,697)(60,558)(42,819)(24,909)(15,658)(13,755)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: